menu
    • menu

    Company profile for Tvardi Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tvardi TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2450 Holcombe Blvd, Suite X Houston, Texas 77021
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tvarditherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tvardi/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tvarditherap

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tvardi Therapeutics Joins Piper Sandler Healthcare Conference
    Tvardi Therapeutics Joins Piper Sandler Healthcare Conference

    18 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251118355835/en/Tvardi-Therapeutics-to-Participate-in-the-Piper-Sandler-37th-Annual-Healthcare-Conference

    BUSINESSWIRE
    18 Nov 2025
    Share Share
    Tvardi Therapeutics Unveils Q3 2025 Results And Business Update
    Tvardi Therapeutics Unveils Q3 2025 Results And Business Update

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113079476/en/Tvardi-Therapeutics-Announces-Third-Quarter-2025-Results-and-Provides-Business-Update

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Tvardi Therapeutics Joins Jefferies Global Healthcare Conference
    Tvardi Therapeutics Joins Jefferies Global Healthcare Conference

    04 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251104976579/en/Tvardi-Therapeutics-to-Participate-in-the-Jefferies-Global-Healthcare-Conference-in-London

    BUSINESSWIRE
    04 Nov 2025
    Share Share
    Tvardi's STAT3 Inhibitor Flunks IPF Trial Amid High Dropout Rate
    Tvardi's STAT3 Inhibitor Flunks IPF Trial Amid High Dropout Rate

    13 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/tvardis-stat3-inhibitor-flunks-phase-2-ipf-trial-amid-high-dropout-rates

    FIERCE BIOTECH
    13 Oct 2025
    Share Share
    Tvardi Therapeutics Updates Preliminary Data From IPF
    Tvardi Therapeutics Updates Preliminary Data From IPF

    13 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251013112813/en/Tvardi-Therapeutics-Provides-Update-on-Preliminary-Data-from-Phase-2-REVERT-Trial-in-Idiopathic-Pulmonary-Fibrosis

    BUSINESSWIRE
    13 Oct 2025
    Share Share
    Tvardi Therapeutics to Join Cantor Global Healthcare Conference
    Tvardi Therapeutics to Join Cantor Global Healthcare Conference

    21 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250821001327/en/Tvardi-Therapeutics-to-Participate-in-the-Cantor-Global-Healthcare-Conference

    BUSINESSWIRE
    21 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search